News

The Manila Times23m
CD8 Technology Signs Letter of Intent for Tevogen Bio's In-House Manufacturing Facility, Marking First Phase of Up to $50 Million Commitment
WARREN, N.J., April 30, 2025 (GLOBE NEWSWIRE) -- Tevogen ("Tevogen Bio Holdings Inc.” or "Company”) (Nasdaq: TVGN) today ...
American Banker52m
Challenges fintechs face when they become banks
Fintechs that want to acquire bank charters face multiple obstacles, from increased regulatory scrutiny to stiff competition ...